Harmon Cyrus

Director · OLMA

As of 2026-09-27, Harmon Cyrus has 28 Form 4 transactions on record across 1 company — 6 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Pattern in the record: open-market sales filed in July in multiple years since 2024 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.

Reconstructed holdings

Direct: $6.1MIndirect: $1.0M$7.2Mas of 2026-09-27
  • Direct $6.1M
  • Indirect $1.0M
OLMAdirect702,770 sh$6.1M
OLMAindirect117,028 sh$1.0M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

OLMA · 28 trades
2026-07-24: Sale, 12,500 sh ($146K)2026-07-23: Sale, 12,500 sh ($145K)2026-06-18: Award / grant, 29,500 sh ($0)2026-01-20: Sale, 10,000 sh ($269K)2026-01-14: Sale, 3,489 sh ($102K)2025-12-22: Sale, 2,881 sh ($82K)2025-09-18: Sale, 10,000 sh ($83K)2025-09-18: Sale, 3,086 sh ($26K)2025-09-16: Sale, 10,000 sh ($80K)2025-09-16: Sale, 1,914 sh ($15K)2025-06-11: Award / grant, 24,150 sh ($0)2024-12-11: Sale, 7,958 sh ($69K)2024-12-11: Sale, 179 sh ($2K)2024-12-10: Sale, 8,256 sh ($77K)2024-12-09: Award / grant, 29,250 sh ($0)2024-07-30: Sale, 934 sh ($15K)2024-07-29: Sale, 4,066 sh ($63K)2024-07-11: Sale, 5,000 sh ($61K)2024-06-28: Sale, 20,000 sh ($215K)2024-06-14: Award / grant, 23,000 sh ($0)2024-06-04: Sale, 5,000 sh ($62K)2024-06-03: Sale, 5,000 sh ($55K)2024-05-31: Sale, 15,000 sh ($141K)2024-05-06: Sale, 5,000 sh ($55K)2024-04-30: Sale, 15,000 sh ($143K)2024-03-28: Sale, 20,000 sh ($219K)2024-02-29: Sale, 24,900 sh ($309K)2024-02-29: Sale, 100 sh ($1K)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-07-24OLMASale12,500 @ $11.71$146K−1.7% of holding702,770Form 4
2026-07-23OLMASale12,500 @ $11.58$145K−1.7% of holding715,270Form 4
2026-01-20OLMASale10,000 @ $26.88$269K−1.4% of holding727,770Form 4
2026-01-14OLMASale3,489 @ $29.12$102K−0.5% of holding737,770Form 4
2025-12-22OLMASale2,881 @ $28.53$82K−0.4% of holding741,259Form 4
2025-09-18OLMASale10,000 @ $8.33$83K−1.3% of holding744,140Form 4
2025-09-18OLMASale3,086 @ $8.32$26K−2.6% of holding117,028Form 4
2025-09-16OLMASale10,000 @ $8.04$80K−1.3% of holding754,140Form 4
2025-09-16OLMASale1,914 @ $8.08$15K−1.6% of holding120,114Form 4
2024-12-11OLMASale7,958 @ $8.66$69K−1.0% of holding764,319Form 4
2024-12-11OLMASale179 @ $9.39$2K−0.0% of holding764,140Form 4
2024-12-10OLMASale8,256 @ $9.37$77K−1.1% of holding772,277Form 4
2024-07-30OLMASale934 @ $15.55$15K−0.1% of holding751,283Form 4
2024-07-29OLMASale4,066 @ $15.58$63K−0.5% of holding752,217Form 4
2024-07-11OLMASale5,000 @ $12.26$61K−0.7% of holding756,283Form 4
2024-06-28OLMASale20,000 @ $10.77$215K−2.6% of holding761,283Form 4
2024-06-04OLMASale5,000 @ $12.33$62K−0.6% of holding781,283Form 4
2024-06-03OLMASale5,000 @ $10.93$55K−0.6% of holding786,283Form 4
2024-05-31OLMASale15,000 @ $9.41$141K−1.9% of holding791,283Form 4
2024-05-06OLMASale5,000 @ $10.92$55K−0.6% of holding806,283Form 4
2024-04-30OLMASale15,000 @ $9.51$143K−1.8% of holding811,283Form 4
2024-03-28OLMASale20,000 @ $10.97$219K−2.4% of holding826,283Form 4
2024-02-29OLMASale24,900 @ $12.41$309K−2.9% of holding846,383Form 4
2024-02-29OLMASale100 @ $13.00$1K−0.0% of holding846,283Form 4
4 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-18OLMAAward / grant29,50029,500Form 4
2025-06-11OLMAAward / grant24,15024,150Form 4
2024-12-09OLMAAward / grant29,250780,533Form 4
2024-06-14OLMAAward / grant23,00023,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.